B cell adaptor for PI3-kinase (BCAP) modulates CD8⁺ effector and memory T cell differentiation

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• CD8+ T cells differentiate into effector and memory cells based on signals like TCR, costimulatory molecules, and cytokines.
• The strength of early phosphoinositide 3-kinase (PI3K) signaling critically impacts T cell differentiation outcomes.
• Understanding molecular mechanisms regulating T cell responses is crucial for immunology and immunotherapy.

Purpose of the Study:

• To investigate the role of B cell adaptor for PI3K (BCAP) in CD8+ T cell activation and differentiation.
• To elucidate how early PI3K signaling influences the development of effector and memory CD8+ T cell populations.
• To identify molecular checkpoints that regulate T cell effector function and memory formation.

Main Methods:

• Analysis of CD8+ T cell responses following T cell receptor (TCR) stimulation.
• Assessment of phosphoinositide 3-kinase (PI3K) signaling pathways and their downstream effects.
• Utilizing BCAP-deficient CD8+ T cells in infection models, specifically with Listeria monocytogenes.
• Evaluating T cell clonal expansion, effector function, and memory cell development.

Main Results:

• Initial PI3K signaling during T cell activation leads to the upregulation of BCAP.
• BCAP potentiates PI3K signaling, promoting CD8+ T cell accumulation with a terminally differentiated effector phenotype.
• BCAP-deficient CD8+ T cells exhibit reduced clonal expansion and altered effector/memory development after Listeria monocytogenes infection.

Conclusions:

• BCAP induction acts as a positive feedback mechanism to amplify PI3K signaling in activated CD8+ T cells.
• BCAP functions as a molecular checkpoint that regulates the development of effector and memory T cell populations.
• Targeting the PI3K-BCAP axis could offer new strategies for modulating adaptive immune responses.